登录后 PLUS 会员 可查看完整内容
微信扫一扫
成为会员后
查看完整内容
文献评审日期:2022-01-01
1. Authors/Task Force M, Galie N, Humbert M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2015, 46(4): 903‑975. DOI:10.1093/eurheartj/ehv317.
2. Hassoun PM, Mouthon L, Barbera JA, et al. Inflammation, growth factors, and pulmonary vascular remodeling[J]. J Am Coll Cardiol, 2009, 54(1 Suppl): S10‑19. DOI: 10. 1016/j.jacc.2009.04.006.
3. Chung L, Liu J, Parsons L, et al. Characterization of connective tissue disease‑associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype[J]. Chest, 2010, 138(6): 1383‑1394. DOI:10.1378/chest.10‑0260.
感谢以下医疗从业者参与贡献
排序不分先后
2020中国结缔组织病相关肺动脉高压诊治专家共识